Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep184 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Diabetes mellitus is associated with a higher relative risk for Parkinson’s disease in women than in men

Deischinger Carola , Dervic Elma , Kaleta Michaela , Klimek Peter , Kautzky-Willer Alexandra

IntroductionIn general, the risk to develop Parkinson’s disease (PD) is higher in men compared to women. Besides male sex and genetics, research suggests diabetes mellitus (DM) is a risk factor for PD as well. In this population-level study, we aimed at investigating the sex-specific impact of DM on the risk of developing PD.Research design and methodsMedical claims data were analyzed in a cross-sectiona...

ea0025pl2biog | Society for Endocrinology Hoffenberg International Medal Lecture | SFEBES2011

Society for Endocrinology Hoffenberg International Medal Lecture

Fuller Peter J

Peter J Fuller, Prince Henry’s Institute, Clayton, Victoria, Australia. AbstractProfessor Fuller is an NHMRC Senior Principal Research Fellow at Prince Henry's Institute of Medical Research in Melbourne where is the Associate Director and Head of the Steroid Receptor Biology Group. He is also Director of the Endocrinology Unit at the Monash Medical Centre/Southern Health and an Adjunct Professor in Medicine and ...

ea0037oc9.1 | Adrenal 2 | ECE2015

Effects of dexamethasone and adrenocorticotropin on circulating microRNA expression in humans

Igaz Ivan , Nyiro Gabor , Nagy Zoltan , Perge Pal , Toth Miklos , Racz Karoly , Igaz Peter , Patocs Attila

Objective: MicroRNAs are short non-protein coding RNA molecules involved in the regulation of numerous homeostatic processes via modulating gene expression. There are some data that the expression of microRNA might be modulated by hormones, but the interaction of hormones and circulating microRNAs of adrenocortical origin is mostly unknown.Methods: The expression of six selected circulating microRNAs (hsa-miR-27a, hsa-miR-125b-2, hsa-miR-200b, hsa-miR-21...

ea0051cme3 | CME Training Day Abstracts | BSPED2017

Glucocorticoid therapy and adrenal suppression

Hindmarsh Peter

Glucocorticoids form the mainstay of many treatment modalities in paediatrics ranging from short term use in asthma to longer term use as anti-inflammatory agents in nephrotic syndrome and rheumatoid disorders. Long term use although effective brings with it the problems of adrenal suppression.When considering weaning a patient from glucocorticoid use consideration needs to be given to the type of glucocorticoid used, duration of treatment, dosage used a...

ea0081ap5.2 | European Hormone Medal Award Lecture | ECE2022

Diabetic kidney disease: after years of darkness came light – finally new options for treatment!

Rossing Peter

Unfortunately diabetes is a growing problem with now more than 537 million people worldwide having diabetes according to International Diabetes Federation. Excess morbidity and mortality in diabetes is related to the development of diabetic kidney disease seen in 30-40%, which not only causes end stage kidney disease, but also increases risk for cardiovascular events and mortality, which is the leading cause of death. Treatment of diabetic kidney disease has been control of gl...

ea0086pl5 | Society for Endocrinology International Medal Lecture | SFEBES2022

Insights into the Cell and Molecular Control Pathways that Regulate Cancers in the Skeleton

Croucher Peter

Early detection, surgery and targeted treatments have seen remarkable improvements in cancer survival. Yet for many patients, cancers still relapse in distant organs after seemingly successful treatment of primary disease. The skeleton is one of the most common sites. Multiple myeloma develops directly in bone, whereas solid tumours, including breast and prostate cancers, spread to bone, often early in the clinical course, giving rise to incurable disease. It remains unclear h...

ea0066p1 | Adrenal, Gonadal, DSD and Reproduction, and Basic Science | BSPED2019

Learning from clearance studies, 24 h profiling and pump therapy – PUTTING the onus on cortisol replacement rather than 17OHP and androstenedione

Hindmarsh Peter

Convention places 17OHP measures as the way to monitor replacement therapy in congenital adrenal hyperplasia due to P450c21 deficiency. One case several years ago led to questioning of this approach as the 17OHP measures suggested inadequate replacement with hydrocortisone using a general dosing regimen of 12 mg/m2/day and questions about compliance. 24 h cortisol profiles showed high 17OHP concentrations with low cortisol concentrations. Careful studies ...

ea0063s15.1 | European Young Endocrine Scientists (EYES) | ECE2019

European Young Endocrine Scientists (EYES) – Organ cross-talk in endocrine disease

Aldiss Peter

‘European Young Endocrine Scientists’ (EYES), founded in 2011, is a committee under the patronage of the European Society of Endocrinology (ESE). Our primary goal is to increase the mutual exchange of ideas and knowledge between early career researchers (ECR’s) across Europe, in both basic and clinical endocrinology. EYES enables ECR’s from all ESE member societies to actively contribute to the society’s activities and help them fully develop into the ...

ea0063s17.3 | Where do pituitary tumours come from? | ECE2019

‘From Lab to Clinic – Can we translate into effective therapeutics’

Kamenicky Peter

The first line treatment of somatotroph adenomas is pituitary surgery, that aims at removing the tumor, but which is frequently incomplete, as invasion into cavernous sinuses often limits the surgical resection. Multimodal medical treatment, which is burdensome, very expensive and has variable therapeutic efficacy, is currently required in more than 60% of the patients. New therapeutic approaches are therefore necessary for controlling hormone secretion, tumor development and ...

ea0049s24.1 | Obesity: Pharmacological solutions | ECE2017

MSH analogs

Kuhnen Peter

The leptin-melanocortin signaling pathway plays a pivotal role in the regulation of body weight within the hypothalamus. Leptin, secreted by the adipose tissue, activates the leptin receptor at the arcuate nucleus, which in turn leads to the production of proopiomelanocortin (POMC) derived peptides as melanocyte stimulating hormone (MSH). MSH activates the melanocortin 4 receptor (MC4R), regulating thereby satiety and energy expenditure. Mutations within this pathway are leadi...